🇺🇸 FDA
Pipeline program

Ifetroban, Oral Capsule

CPI-IFE-003

Phase 2 small_molecule completed

Quick answer

Ifetroban, Oral Capsule for Aspirin Exacerbated Respiratory Disease (AERD) is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Aspirin Exacerbated Respiratory Disease (AERD)
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials